From concept to completion, the entire process took three weeks and is providing COVID-19 testing professionals with a permanent facility that provides a secure and comfortable environment.
Having used tents for COVID-19 testing, the university turned to PCL Construction for a more permanent solution to safely conduct testing through changing weather conditions.
The 40-foot pod can test individuals who either walk or drive-up.
Unlike tents, the pod offers a secure, safe and comfortable environment with climate control, HEPA filters, heating, air conditioning and positive air pressurization. It also is ADA compliant.
The testing pods are easily modified for future use in administering a COVID-19 vaccine, as well as for flu and other viruses. Click here to see a video of the Care Pod's installation.
Utilising modular construction methods, PCL Construction is manufacturing and assembling the pods by retrofitting shipping containers to support rapid delivery and installation.
Heating, air-conditioning, and high-efficiency particulate HEPA filters for mechanical ventilation units are standard features.
Citizen Care Pod also offers an Education Pod and a Long-Term Care Visiting Pod.
Pfizer reports positive Phase 3 data for ABRYSVO in adults at risk for RSV disease
Clover Bio announces SCB-1019 vaccine candidate Phase I trial data in initial young adult cohort
Sanofi launches Verorab for rabies prophylaxis in UK
BioVaxys expands patent portfolio for DPX delivery platform and advances DPX SurMAGE
YS Biopharma repays USD40m loan facility
Kintara Therapeutics and TuHURA Biosciences to merge
VGXI names new chief accounting officer
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Valneva launches Phase 1 trial for next-generation Zika vaccine
Circio Holding ASA confirms licensing deal with IOVaxis Therapeutics in China and Singapore
Everest Medicines names new chief medical officer and chief product officer
Pfizer's PREVENAR 20 gains European Commission approval for paediatric pneumococcal vaccine